Evan Rachlin Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Investments
  • 2

  • Exits
  • 1


Evan Rachlin General Information


Dr. Evan Rachlin is a Co-Founder and serves as Managing Partner at Ascenta Capital. He serves as Managing Director at Blackstone Life Sciences. He served as Head of Strategy at Moderna Therapeutics. He also served as a Board Member at Fergene. He serves as Principal at Bain Capital Ventures. He joined Bain Capital Ventures in 2012 to focus on healthcare. Prior to joining Bain Capital, he was an engagement manager in McKinsey & Company's New York office. At McKinsey, he focused on healthcare strategy, operations, and due diligence, particularly in the CRO, mobile health, and systems biology sectors. Before starting at McKinsey in 2010, While pursuing his MD/MBA, he also worked for a regenerative medicine startup and did a summer internship at Pfizer's Portfolio & Decision Analysis group in New York. He received his AB magna cum laude from Harvard College in biochemistry with a language citation in Japanese. While in college, he was editor in chief of Venture, a high-tech entrepreneurship magazine run by Harvard students, which received the nation's highest collegiate publishing award. He received his MD/MBA from Harvard Medical and Business Schools, where he was the co-president of the MD/MBA Association, an officer of the Venture Capital/Private Equity Club, and captain of the Harvard Medical Area soccer team.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • New York, NY
  • United States
+1 (617) 000-0000

Evan Rachlin Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Augmedix 31-May-2015 Early Stage VC 000.00 Medical Records Systems Generating Revenue/Not Profitable 0000 0000000 00
Augmedix 31-May-2014 0000 00000 00.000 Medical Records Systems Generating Revenue/Not Profitable 0000 0000000 00

Evan Rachlin Exits (1)

Company Name Exit Date Exit Type Exit Size
Augmedix 06-Oct-2020 0000000 000000

Evan Rachlin Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Evan Rachlin Team (1)

Name Title Deals Funds Boards Office
Evan Rachlin MD Angel Investor 0 New York, NY

Evan Rachlin FAQs

  • Who is Evan Rachlin?

    Evan Rachlin is an angel Investor who has made 2 investments.

  • What kind of investor is Evan Rachlin?

    Evan Rachlin is an angel investor.

  • What does Evan Rachlin do?

    As an angel investor, Evan Rachlin invests personal money into promising companies, typically in exchange for equity.

  • What has Evan Rachlin invested in?

    Evan Rachlin has invested in Augmedix within the Medical Records Systems industry.

  • What has Evan Rachlin invested in recently?

    Evan Rachlin's latest investment was on 31-May-2015 in Augmedix, a company within the Medical Records Systems industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »